gemcitabine,paclitaxel
Not Tagged
['pancsm', 'paclitaxel', 'gemcitabine', 'pancreatic']
nalirifox can improve survival vs gemcitabine plus nab-paclitaxel in patients with previously untreated, metastatic pancreatic ductal adenocarcinoma, a phase 3 trial presented at asco 2023 suggests. #asco23 #pancsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.